contact usfaqupdatesindexconversations
missionlibrarycategoriesupdates

Columbia Seligman Global Technology Fund Expresses Caution Over NVIDIA's Customer Concentration

November 28, 2024 - 06:10

Columbia Seligman Global Technology Fund Expresses Caution Over NVIDIA's Customer Concentration

Columbia Threadneedle Investments recently shared insights from its third quarter 2024 investor letter for the Columbia Seligman Global Technology Fund. The letter highlights the performance of equity markets, noting a 6.08% increase in the large-cap Russell 1000 Index during the third quarter, which brings its year-to-date return to an impressive 21.18%.

Despite the positive market trends, the fund's management has raised concerns regarding NVIDIA Corporation's high customer concentration. This caution reflects a broader strategy aimed at navigating potential risks associated with reliance on a limited number of clients. The fund continues to evaluate its positions carefully in light of these dynamics.


MORE NEWS

Space Force Turns to Laser Systems to Shield Launch Sites from Drone Threats

September 30, 2026 - 01:50

Space Force Turns to Laser Systems to Shield Launch Sites from Drone Threats

The U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...

DIU Seeks Investors in Counter-Unmanned Systems Technology

September 29, 2026 - 04:58

DIU Seeks Investors in Counter-Unmanned Systems Technology

The Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...

Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing Agreement

September 28, 2026 - 02:02

Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing Agreement

Novo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...

New Biochip Enables Real-Time Tracking of Parkinson's Treatment Response

September 27, 2026 - 08:32

New Biochip Enables Real-Time Tracking of Parkinson's Treatment Response

Researchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...

read all news
contact usfaqupdatesindexeditor's choice

Copyright © 2026 Tech Warps.com

Founded by: Adeline Taylor

conversationsmissionlibrarycategoriesupdates
cookiesprivacyusage